Eastman Chemical
Makes specialty materials, additives, chemical intermediates, and fibers for global industrial and consumer applications.
Something off on this page? Send us feedback.
Profile
Sells performance polymers, films, plastics, specialty additives, functional chemicals, integrated intermediates, and cellulose-based fibers through four operating segments. A global manufacturing network remains centered on the integrated Kingsport site, while internally developed products, acquired specialty platforms, and commercial molecular recycling shape the portfolio.
Produces specialty materials and chemicals across Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers. The portfolio covers performance polymers, films and plastics; specialty additives and functional chemicals; integrated chemical intermediates; and cellulose acetate tow, yarns, fibers, and nonwovens.
Combines internally developed products such as Tritan with specialty platforms acquired through Solutia and Taminco, while commercial molecular recycling extends the polyester business. Manufacturing spans multiple countries, with Kingsport serving as headquarters and the largest integrated site.
Execution depends on reliable feedstocks, energy, transportation, site equipment, and regulatory compliance. Kingsport concentration means utility or equipment failures can interrupt multiple operations, while global facilities rely on formal product-stewardship, process-safety, environmental, and audit systems.
Company facts
Key statistics
Year to date +13.5% · Average volume (30d) 1.1M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | UBS | Reiterate | Buy | $88 | $92 | |
| Aug 3, 2026 | Deutsche Bank | Reiterate | Hold | $82 | $74 | |
| Jul 16, 2026 | Goldman Sachs | Reiterate | Neutral | $89 | $75 | |
| Jul 2, 2026 | Morgan Stanley | Reiterate | Overweight | $83 | $79 | |
| May 5, 2026 | Morgan Stanley | Reiterate | Overweight | $115 | $83 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $1.82 | $1.97 | +8.2% | $2.40B | $2.51B | +4.8% | −0.17% |
| Apr 30, 2026Q1 FY26 | $1.07 | $1.09 | +1.9% | $2.17B | $2.18B | +0.2% | +6.07% |
| Jan 29, 2026Q4 FY25 | $0.76 | $0.75 | −1.3% | $2.02B | $1.97B | −2.3% | +0.48% |
| Nov 3, 2025Q3 FY25 | $1.16 | $1.14 | −1.7% | $2.26B | $2.20B | −2.5% | +4.92% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.29B | $2.29B | $2.20B | $1.97B | $2.18B | $2.51B | |
| Gross profit | $567.0M | $506.0M | $433.0M | $338.0M | $431.0M | $560.0M | |
| Operating income | $318.0M | $284.0M | $210.0M | $121.0M | $193.0M | $310.0M | |
| Net income | $182.0M | $140.0M | $47.0M | $105.0M | $107.0M | $183.0M | |
| Diluted EPS | $1.57 | $1.20 | $0.41 | $0.92 | $0.93 | $1.59 | |
| Gross margin | 24.8% | 22.1% | 19.7% | 17.1% | 19.8% | 22.3% | |
| Operating margin | 13.9% | 12.4% | 9.5% | 6.1% | 8.9% | 12.3% |
Fiscal years (4-quarter sums)FY21 $10.48B · FY22 $10.54B · FY23 $9.20B · FY24 $9.38B · FY25 $8.75B
Revenue by product · Q2 FY26
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $691.0M · Total debt $5.22B · Total assets $15.42B · Shareholders' equity $6.10B
Dividends
Raised for 31 straight years — most recently to $0.84 from $0.83 in Dec 2025. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 15, 2026 | Jun 15 | Jul 8 | $0.84 | |
| Mar 13, 2026 | Mar 13 | Apr 8 | $0.84 | |
| Dec 15, 2025 | Dec 15 | Jan 8 | $0.84 | raised from $0.83 |
| Sep 15, 2025 | Sep 15 | Oct 7 | $0.83 | |
| Jun 13, 2025 | Jun 13 | Jul 8 | $0.83 | |
| Mar 14, 2025 | Mar 14 | Apr 7 | $0.83 | |
| Dec 16, 2024 | Dec 16 | Jan 8 | $0.83 | raised from $0.81 |
| Sep 16, 2024 | Sep 16 | Oct 7 | $0.81 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 114.35M · Float 113.20M · 99.0% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 16.94M | 14.81% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 7.55M | 6.61% | 13F | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 5.16M | 4.52% | 13F | Aug 11, 2026 |
| Vanguard Capital Management LLC | 5.16M | 4.51% | 13F | Aug 13, 2026 |
| State Street Corp | 4.17M | 3.65% | 13F | Aug 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 4, 2026 | Adrian James Holt | officer: SVP, Chf HR Ofcr | −3,283 | $71.31 |
| May 5, 2026 | Adrian James Holt | officer: SVP, Chf HR Ofcr | −1,709 | $77.05 |
| Aug 27, 2025 | Brian Travis Smith | officer: EVP, AFP, Mfg., WWEC & HSE | +1,750 | $68.34 |
Peers
- Celanese
Direct overlap in acetyls, acetate tow, and coatings materials
- Dow
Overlap in coatings inputs, specialty fluids, and intermediates
- XPEL
Focused rival in automotive and architectural protective films
